基于电子健康记录的持续低氧中重度急性呼吸窘迫综合征分类器
本研究为回顾性观察研究,在6个ICU中纳入接受有创机械通气≥24小时且初始72小时内PaO2/FiO2≤150 mmHg(FiO2≥0.6)的成人患者。开发队列924例中504例(55%)经临床判定为ARDS,验证队列90例中48例(53%)为ARDS。主要分类器要求初始低氧后24小时内持续PaO2/FiO2≤150 mmHg或接受俯卧位、神经肌肉阻滞、吸入肺血管扩张剂等干预,开发队列识别382例、验证队列识别38例,阳性预测值分别为71%(95%CI 66-75)和66%(95%CI 50-81)。若以SpO2/FiO2≤162作为第二低氧标志,更多患者被分类为ARDS但阳性预测值降低(67%和62%)。作者认为该开源工具可用于回顾性或前瞻性识别该脆弱人群以支持研究和质量改进。
要点
- 开发队列924例中504例(55%)为临床判定ARDS,验证队列90例中48例(53%)为ARDS。
- 主要分类器在开发队列识别382例持续中重度ARDS,阳性预测值71%(95%CI 66-75)。
- 主要分类器在验证队列识别38例,阳性预测值66%(95%CI 50-81)。
- 以SpO2/FiO2≤162替代PaO2/FiO2作为第二低氧标志时,两队列分类为ARDS的患者增多但阳性预测值降低(67%和62%)。
- 作者认为该开源工具可用于回顾性或前瞻性识别持续中重度ARDS患者,供研究和质量改进使用。
适用人群与场景
- 成人患者,接受有创机械通气≥24小时,且在初始72小时内PaO2/FiO2≤150 mmHg且FiO2≥0.6。
- 开发队列来自两个学术医疗中心之一或三个混合社区ICU,时间为2021年前3个月或2022-2023年;验证队列来自另一学术医疗ICU,时间为2017年。
诊断标准与关键阈值
- 临床ARDS标准由研究医师评估判定。
- 电子健康记录分类器要求:初始满足低氧标准后24小时内持续PaO2/FiO2≤150 mmHg,或接受针对严重低氧的干预(俯卧位、神经肌肉阻滞、吸入肺血管扩张剂)。
- 替代定义使用SpO2/FiO2≤162作为持续低氧标志。
研究设计与关键结果
- 研究类型为回顾性观察研究,纳入6个ICU(两个卫生系统)的成人患者。
- 开发队列924例中504例(55%)为临床判定ARDS;验证队列90例中48例(53%)为ARDS。
- 主要分类器在开发队列识别382例持续中重度ARDS,阳性预测值71%(95%CI 66-75);在验证队列识别38例,阳性预测值66%(95%CI 50-81)。
- 使用SpO2/FiO2≤162作为第二低氧标志时,开发队列和验证队列分类为ARDS的患者数均增多,阳性预测值分别为67%和62%。
证据类型、等级与局限
- 证据类型:回顾性观察研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为该基于电子健康记录的开源分类器可用于回顾性或前瞻性识别持续中重度ARDS患者,以支持研究和质量改进。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: To characterize the performance of an electronic health record (EHR) data-based classifier of persistent moderate-to-severe acute respiratory distress syndrome (ARDS).
DESIGN: Retrospective observational study.
SETTING: Six ICUs from two health systems.
PATIENTS: We included adults receiving greater than or equal to 24 hours of invasive mechanical ventilation (IMV) with a Pa o2 /F io2 of less than or equal to 150 mm Hg on F io2 greater than or equal to 0.6 in the first 72 hours of IMV. We evaluated classifier performance in two temporally and geographically distinct cohorts: a development cohort including patients in one of two academic medical or three mixed community ICUs in the first 3 months of 2021 or in 2022-2023, and a validation cohort from a different academic medical ICU in 2017.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: In both cohorts, study physicians assessed patients for clinical ARDS criteria. We retrospectively applied the EHR classifier, which required a persistent Pa o2 /F io2 of less than or equal to 150 mm Hg or receipt of interventions to address severe hypoxemia (i.e., prone positioning, neuromuscular blockade, inhaled pulmonary vasodilators) in the 24 hours after initially meeting hypoxemia criteria. We also evaluated classifier definitions that used peripheral oxygen saturation (Sp o2 )/F io2 of less than or equal to 162 to indicate persistent hypoxemia. Of 924 patients in the development cohort, 504 (55%) had clinician-adjudicated ARDS. Of 90 patients in the validation cohort, 48 (53%) had clinician-adjudicated ARDS. In the development and validation cohorts, the primary EHR-based classifier identified 382 and 38 patients as having persistent moderate-to-severe ARDS, respectively (positive predictive value [PPV], 71%; 95% CI, 66-75% and PPV, 66%; 95% CI, 50-81%). When Sp o2 /F io2 was used as the second hypoxemia marker more patients were classified as ARDS in both development and validation cohorts but with lower PPVs (67% and 62%, respectively.).
CONCLUSIONS: An EHR-based classifier using readily available data had acceptable performance for identifying patients with persistent moderate-severe ARDS. This open-source tool could be used for retrospective or prospective identification of this vulnerable population for research and quality improvement initiatives.
参考来源
- Hochberg CH, Barker AK, Alsagban A, et al. An Electronic Health Record-Based Classifier for Moderate-to-Severe Acute Respiratory Distress Syndrome With Persistent Hypoxemia. Crit Care Med. 2025. PMID: 41467760. doi:10.1097/CCM.0000000000007007
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。